SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B3 - Prospectus [Rule 424(b)(3)]:
SEC Accession No. 0001683168-24-001696
Filing Date
2024-03-26
Accepted
2024-03-26 06:30:20
Documents
8

Document Format Files

Seq Description Document Type Size
1 PROSPECTUS 424B3 coeptis_424b3.htm 424B3 995509
2 GRAPHIC image_001.jpg GRAPHIC 6282
3 GRAPHIC image_007.jpg GRAPHIC 2148
4 GRAPHIC image_008.jpg GRAPHIC 2148
5 GRAPHIC image_009.jpg GRAPHIC 1197
6 GRAPHIC image_010.jpg GRAPHIC 1197
7 GRAPHIC image_011.jpg GRAPHIC 1197
8 GRAPHIC image_012.jpg GRAPHIC 11061
  Complete submission text file 0001683168-24-001696.txt   1032355
Mailing Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090
Business Address 105 BRADFORD ROAD, SUITE 420 WEXFORD PA 15090 724-934-6467
Coeptis Therapeutics Holdings, Inc. (Filer) CIK: 0001759186 (see all company filings)

IRS No.: 981465952 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B3 | Act: 33 | File No.: 333-269782 | Film No.: 24780849
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)